TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06818448: Pre-market Clinical Investigation Inovedis SINEFIX

Sponsor: BAAT Medical Products B.V. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 60 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$7,038,400

Rescue Site Savings

+$4,648,000

Unlock Full NCT06818448 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06818448 Rescue Dossier →